Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,128 | 2,485 | 1,860 | -222 | 1,517 |
| Cost of Goods | 17 | 51 | 14 | 13 | 79 |
| Gross Profit | 2,111 | 2,434 | 1,846 | -235 | 1,438 |
| Operating Expenses | 6,335 | 6,488 | 5,581 | 4,494 | 4,330 |
| Operating Income | -4,207 | -4,003 | -3,721 | -4,716 | -2,813 |
| Interest Expense | 2 | 0 | 0 | 0 | 0 |
| Other Income | -46 | -8,448 | 301 | 500 | 173 |
| Pre-tax Income | -4,255 | -12,451 | -3,420 | -4,216 | -2,640 |
| Net Income Continuous | -4,255 | -12,451 | -3,420 | -4,216 | -2,640 |
| Net Income | $-4,255 | $-12,451 | $-3,420 | $-4,216 | $-2,640 |
| EPS Basic Total Ops | -3.51 | -10.28 | -2.80 | -3.48 | -2.16 |
| EPS Basic Continuous Ops | -3.51 | -10.26 | -2.82 | -3.47 | -2.17 |
| EPS Diluted Total Ops | -3.51 | -10.28 | -2.80 | -3.48 | -2.16 |
| EPS Diluted Continuous Ops | -3.51 | -10.26 | -2.82 | -3.47 | -2.17 |
| EBITDA(a) | $-4,927 | $-3,724 | $-4,936 | $-4,557 | $-3,605 |